← Leaderboards
Karen Sang Chen
Imago Pharmaceuticals, Inc.
$282,424
Attributed
$282,424
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$282,424 · 1
By mechanism
R43$282,424 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAchievementBrain RegionAffectBehaviorAmyloid Beta-ProteinAnimal ModelAntibodiesAstrocytosisAutoimmune DiseasesDrug TargetingBehavioralBrainBrain PathologyActive SitesClinical CandidateClinical DevelopmentCognitive AbilityDepositionDisease ProgressionDrug CandidateDrug KineticsAbeta SynthesisAbeta Accumulation